252 related articles for article (PubMed ID: 18091640)
1. Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy.
Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Loperfido F; Biondi-Zoccai G
Minerva Cardioangiol; 2007 Dec; 55(6):711-20. PubMed ID: 18091640
[TBL] [Abstract][Full Text] [Related]
2. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
Boyd A; Stoodley P; Richards D; Hui R; Harnett P; Vo K; Marwick T; Thomas L
PLoS One; 2017; 12(4):e0175544. PubMed ID: 28407011
[TBL] [Abstract][Full Text] [Related]
3. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.
Tassan-Mangina S; Codorean D; Metivier M; Costa B; Himberlin C; Jouannaud C; Blaise AM; Elaerts J; Nazeyrollas P
Eur J Echocardiogr; 2006 Mar; 7(2):141-6. PubMed ID: 15941672
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
[TBL] [Abstract][Full Text] [Related]
5. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study.
Nagy AC; Cserép Z; Tolnay E; Nagykálnai T; Forster T
Pathol Oncol Res; 2008 Mar; 14(1):69-77. PubMed ID: 18347931
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
8. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
[TBL] [Abstract][Full Text] [Related]
9. Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up.
Elitok A; Oz F; Cizgici AY; Kilic L; Ciftci R; Sen F; Bugra Z; Mercanoglu F; Oncul A; Oflaz H
Cardiol J; 2014; 21(5):509-15. PubMed ID: 24142687
[TBL] [Abstract][Full Text] [Related]
10. Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy.
Pignatelli RH; Ghazi P; Reddy SC; Thompson P; Cui Q; Castro J; Okcu MF; Jefferies JL
Pediatr Cardiol; 2015 Dec; 36(8):1610-6. PubMed ID: 26049414
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline chemotherapy impairs the structure and diastolic function of the left ventricle and induces negative arterial remodelling.
Mizia-Stec K; Gościńska A; Mizia M; Haberka M; Chmiel A; Poborski W; Gąsior Z
Kardiol Pol; 2013; 71(7):681-90. PubMed ID: 23907900
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
[TBL] [Abstract][Full Text] [Related]
13. Time course of recovery of left ventricular systolic dysfunction in patients with premature ventricular contraction-induced cardiomyopathy.
Hasdemır C; Kartal Y; Sımsek E; Yavuzgıl O; Aydın M; Can LH
Pacing Clin Electrophysiol; 2013 May; 36(5):612-7. PubMed ID: 23379975
[TBL] [Abstract][Full Text] [Related]
14. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction.
Poterucha JT; Kutty S; Lindquist RK; Li L; Eidem BW
J Am Soc Echocardiogr; 2012 Jul; 25(7):733-40. PubMed ID: 22578518
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.
Stoodley PW; Richards DA; Hui R; Boyd A; Harnett PR; Meikle SR; Clarke J; Thomas L
Eur J Echocardiogr; 2011 Dec; 12(12):945-52. PubMed ID: 21965152
[TBL] [Abstract][Full Text] [Related]
16. Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.
Janbabai G; Nabati M; Faghihinia M; Azizi S; Borhani S; Yazdani J
Cardiovasc Toxicol; 2017 Apr; 17(2):130-139. PubMed ID: 27003392
[TBL] [Abstract][Full Text] [Related]
17. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.
Krejci J; Hude P; Poloczkova H; Zampachova V; Stepanova R; Freiberger T; Nemcova E; Spinarova L
Heart Vessels; 2016 Mar; 31(3):416-26. PubMed ID: 25539624
[TBL] [Abstract][Full Text] [Related]
18. Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist.
Mornoş C; Petrescu L
Can J Physiol Pharmacol; 2013 Aug; 91(8):601-7. PubMed ID: 23889668
[TBL] [Abstract][Full Text] [Related]
19. Temporal changes in standard and tissue Doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer.
Lotrionte M; Cavarretta E; Abbate A; Mezzaroma E; De Marco E; Di Persio S; Loperfido F; Biondi-Zoccai G; Frati G; Palazzoni G
Am J Cardiol; 2013 Oct; 112(7):1005-12. PubMed ID: 23768465
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A
J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
